HSK38008

News alerts, weekly reports and conference planners

Company:

Haisco

Drug class:

AR-V7 degrader

‹

›

AR splice variant 7	Prostate Cancer	AR splice variant 7	Prostate Cancer	enzalutamide capsule + HSK38008 Sensitive: D – Preclinical enzalutamide capsule + HSK38008 Sensitive : D	enzalutamide capsule + HSK38008 Sensitive: D – Preclinical enzalutamide capsule + HSK38008 Sensitive : D
AR splice variant 7	Prostate Cancer	AR splice variant 7	Prostate Cancer	HSK38008 Sensitive: D – Preclinical HSK38008 Sensitive : D	HSK38008 Sensitive: D – Preclinical HSK38008 Sensitive : D

Associations
(2)